Sandoz Group (OTCMKTS:SDZNY) Reaches New 52-Week High – Here’s Why

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) reached a new 52-week high during trading on Thursday. The company traded as high as $103.27 and last traded at $102.77, with a volume of 6,160 shares trading hands. The stock had previously closed at $101.21.

Analyst Upgrades and Downgrades

Separately, Erste Group Bank upgraded shares of Sandoz Group to a “strong-buy” rating in a research report on Thursday, August 27th. Four investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Strong Buy”.

Sandoz Group Price Performance

The stock has a 50-day moving average price of $88.79 and a 200 day moving average price of $84.73.

Sandoz Group Company Profile

Sandoz Group AG is a Switzerland-based pharmaceutical company focused on developing, manufacturing and marketing generic medicines and biosimilars. Its products provide lower-cost alternatives to branded drugs after patents or other exclusivities expire.

The company serves patients and healthcare providers in markets around the world. Its portfolio spans a range of therapeutic areas and includes both small-molecule generics and biologic medicines, including biosimilars.

Sandoz was formerly the generics and biosimilars business of Novartis and became an independent company in 2023.